Chargement...

Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart

13 December 2023

Procedure took place simultaneously in Beijing and Urumqi, carried out entirely via 5G connection with R-One™ robotic platform

Rouen, France, December 13, 2023 – Robocath, a company that designs, develops and markets innovative robotic solutions for treating cardiovascular diseases, today announces it performed a First-in-Human robotic coronary angioplasty from 1,700 miles (2,800 km) away. Two interventional cardiologists, Prof. Yundai Chen in Beijing and Prof. Yining Yang in Urumqi, the capital of the Xinjiang Uygur Autonomous Region, performed the procedure. This world-first, performed…

Learn more

Robocath demonstrates feasibility of robotic carotid stenting in ‘CARE’ clinical trial conducted at Rennes University Hospital

19 October 2023

• 100% clinical success rate: zero complications linked to robot at day 0 and day 30
• R-One™ obtained 86% technical success rate

Rouen and Rennes, France, October 19, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment of cardiovascular diseases, today announces the results of its ‘CARE’ clinical trial focusing on robotic carotid stenting (1). This study is the first phase in an ambitious research program launched in July…

Learn more
Subscribe to our newsletter